Actuated Medical

Neurology & CNS Therapeutics

Overview

Precision Brain Access for Deep Brain Therapies Millions of patients with Parkinson's disease, Alzheimer's disease, brain cancer, epilepsy, and other neurological disorders depend on therapies that must reach precise locations within the brain to be effective.

Funding and backers

Team
11-50
employees, estimated range
Grants
$30.9M
32 grants · CORDIS
Backers
1
Charlottesville Angel Network
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 15, 2024 Won a grant $331k · CORDIS Jun 1, 2024 Won a grant $2.4M · CORDIS Sep 30, 2023 Won a grant $456k · CORDIS Jul 1, 2023 Won a grant $2.2M · CORDIS Sep 30, 2022 Won a grant $2.9M · CORDIS Sep 5, 2022 Won a grant $555k · CORDIS Sep 1, 2022 Won a grant $766k · CORDIS Sep 1, 2022 Won a grant $385k · CORDIS Mar 1, 2022 Won a grant $1.8M · CORDIS Jul 1, 2021 Won a grant $1000k · CORDIS May 1, 2021 Won a grant $310k · CORDIS Feb 9, 2021 Won a grant $166k · CORDIS Sep 30, 2020 Won a grant $2.9M · CORDIS May 5, 2020 Won a grant $528k · CORDIS May 1, 2020 Won a grant $2M · CORDIS Apr 1, 2020 Won a grant $333k · CORDIS Aug 6, 2019 Won a grant $743k · CORDIS May 2, 2019 Won a grant $1.2M · CORDIS Mar 15, 2019 Won a grant $249k · CORDIS Jan 15, 2019 Won a grant $296k · CORDIS Sep 5, 2018 Won a grant $225k · CORDIS Aug 7, 2018 Won a grant $265k · CORDIS Aug 1, 2018 Won a grant $379k · CORDIS Jul 27, 2018 Won a grant $125k · CORDIS May 1, 2018 Won a grant $1.4M · CORDIS Sep 21, 2017 Won a grant $345k · CORDIS Jul 1, 2017 Won a grant $1.5M · CORDIS Sep 1, 2016 Won a grant $224k · CORDIS Jun 23, 2016 Won a grant $1.5M · CORDIS May 18, 2016 Won a grant $274k · CORDIS Apr 1, 2016 Won a grant $1.5M · CORDIS Feb 1, 2016 Won a grant $1.5M · CORDIS
Funding rounds
RoundDateAmountInvestorsSource
Grant Jul 2024 $331k — CORDIS
Grant Jun 2024 $2.4M — CORDIS
Grant Sep 2023 $456k — CORDIS
Grant Jul 2023 $2.2M — CORDIS
Grant Sep 2022 $2.9M — CORDIS
Grant Sep 2022 $555k — CORDIS
Grant Sep 2022 $385k — CORDIS
Grant Sep 2022 $766k — CORDIS
Grant Mar 2022 $1.8M — CORDIS
Grant Jul 2021 $1000k — CORDIS
Grant May 2021 $310k — CORDIS
Grant Feb 2021 $166k — CORDIS
Grant Sep 2020 $2.9M — CORDIS
Grant May 2020 $528k — CORDIS
Grant May 2020 $2M — CORDIS
Grant Apr 2020 $333k — CORDIS
Grant Aug 2019 $743k — CORDIS
Grant May 2019 $1.2M — CORDIS
Grant Mar 2019 $249k — CORDIS
Grant Jan 2019 $296k — CORDIS
Grant Sep 2018 $225k — CORDIS
Grant Aug 2018 $265k — CORDIS
Grant Aug 2018 $379k — CORDIS
Grant Jul 2018 $125k — CORDIS
Grant May 2018 $1.4M — CORDIS
Grant Sep 2017 $345k — CORDIS
Grant Jul 2017 $1.5M — CORDIS
Grant Sep 2016 $224k — CORDIS
Grant Jun 2016 $1.5M — CORDIS
Grant May 2016 $274k — CORDIS
Grant Apr 2016 $1.5M — CORDIS
Grant Feb 2016 $1.5M — CORDIS
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Lario TherapeuticsVenture round · 16 mo ago · Founded 2021 · 11-50 employees
Lario Therapeutics are developing first-in-class disease modifying treatments for severe neurological disorders. Precision Neuroscience…
Five DiscoveryConvertible Note $150k · 9 mo ago · Founded 2025
Five Discovery is a regenerative neurology biotech developing non-hallucinogenic neuroplastogens to repair brain circuits in Parkinson’s…
Damona PharmaceuticalsSeed $5.5M · 4 yr ago · 51-200 employees
Damona Pharmaceuticals is developing precision neuromedicines to reverse cognitive deficits associated with brain disorders.associated with…
Vanqua BioVenture round $45M · 2 yr ago · Founded 2019 · 201-500 employees
Our Mission. Deliver medicines that transform the lives of patients with neurodegenerative diseases.
MODAGSeries A $14M · 7 yr ago
Weltweit sind ca. 10 Millionen Menschen von Parkinson betroffen. Parkinson ist nach der Alzheimer-Krankheit die häufigste neurodegenerative…
NRG TherapeuticsVenture round · 8 mo ago · Founded 2018 · 201-500 employees
Restoring energy. Next-generation disease-modifying medicines for ALS and Parkinson's.

Financials

Total raised
$30.9M
Latest round
Grant
Funding rounds
32
Funding rounds
Round Announced Amount
Grant 2024 $331k Details
Grant 2024 $2.4M Details
Grant 2023 $456k Details
Grant 2023 $2.2M Details
Grant 2022 $2.9M Details
Grant 2022 $555k Details
Grant 2022 $385k Details
Grant 2022 $766k Details
Grant 2022 $1.8M Details
Grant 2021 $1000k Details
Grant 2021 $310k Details
Grant 2021 $166k Details
Grant 2020 $2.9M Details
Grant 2020 $528k Details
Grant 2020 $2M Details
Grant 2020 $333k Details
Grant 2019 $743k Details
Grant 2019 $1.2M Details
Grant 2019 $249k Details
Grant 2019 $296k Details
Grant 2018 $225k Details
Grant 2018 $265k Details
Grant 2018 $379k Details
Grant 2018 $125k Details
Grant 2018 $1.4M Details
Grant 2017 $345k Details
Grant 2017 $1.5M Details
Grant 2016 $224k Details
Grant 2016 $1.5M Details
Grant 2016 $274k Details
Grant 2016 $1.5M Details
Grant 2016 $1.5M Details

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Bellefonte United States
HQ
10-50 est. staff